BRUKER CORP (BRKR)
US1167941087 - Common Stock
BRKR Stock Earnings: Bruker Beats EPS, Misses Revenue for Q1 2024
BRKR stock results show that Bruker beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Bruker Reports First Quarter 2024 Financial Results
Bruker Completes Acquisition of Molecular Diagnostics Innovator ELITech
Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference
Bruker Announces Date and Time of First Quarter 2024 Earnings Release and Webcast
Bruker to Acquire the NanoString Business in an Asset Deal
Interesting BRKR Put And Call Options For December 20th
Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research
/PRNewswire/ -- Biognosys, a global leader in mass spectrometry-based proteomics, and Alamar Biosciences, Inc., a company powering precision proteomics to...
Bruker Selected as ‘Company of the Year’ by Instrument Business Outlook
Shockwave Medical Stock Sees Relative Strength Rating Ride Higher
On Wednesday, Shockwave Medical stock got a positive adjustment to its Relative Strength (RS) Rating, from 90 to 94.
Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO
Bruker Announces Closing of Chemspeed Technologies AG Acquisition
Bruker to buy ELITechGroup for €870M (NASDAQ:BRKR)
Bruker Corporation plans to acquire ELITechGroup for €870M in cash, with the transaction expected to close in Q2 2024.
Bruker Announces Share Purchase Agreement to Acquire Molecular Diagnostics Innovator ELITechGroup
Bruker Corporation to Present at Upcoming Investor Conferences
The 3 Best Nasdaq Stocks to Buy in February 2024
These three Nasdaq stocks to buy now offer solid growth prospects, favorable starting valuations, and some dividend income in one package.
The 3 Best Nasdaq Stocks to Buy in February 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The Nasdaq is off to a scorching start in 2024. The Nasdaq 100 Index is making ...
Bruker Announces Quarterly Dividend
JP Morgan upgrades Bruker to overweight, cites guidance (NASDAQ:BRKR)
JP Morgan upgraded Bruker (BRKR) to overweight, citing its better-than-expected 2024 guidance and pull-forward of its 2026 revenue and non-GAAP EPS LRP targets
Bruker Reports Fourth Quarter and Full Year 2023 Financial Results
Bruker Acquires Nanophoton Corporation, a Japanese Technology Leader in Research Raman Microscopy with 20 Years of Experience
Bruker acquires Spectral Instruments Imaging company (NASDAQ:BRKR)
Bruker Corporation has acquired Spectral Instruments Imaging, expanding its preclinical imaging portfolio in in-vivo optical imaging.
Bruker Acquires Spectral Instruments Imaging, the Performance Leader in Preclinical In-Vivo Optical Imaging Systems
Bruker Announces Date and Time of Fourth Quarter 2023 Earnings Release and Webcast
Bruker Introduces the Ingenious Novel ‘Triceratops’ SPR #64 Surface Plasmon Resonance System for Drug Discovery at SLAS2024
Bruker Moves Up In Market Cap Rank, Passing DaVita
Bruker Stock Rising, Near Buy Point; Gets Rating Upgrade
A Relative Strength Rating upgrade for Bruker stock shows improving technical performance. Will it continue?